These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3953431)

  • 1. Calcium antagonists in systemic hypertension: focus on verapamil. Concluding remarks. Part I.
    Laragh JH
    Am J Cardiol; 1986 Feb; 57(7):87D-89D. PubMed ID: 3953431
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium antagonism--a new concept for treating essential hypertension.
    Müller FB; Bolli P; Erne P; Kiowski W; Bühler FR
    Am J Cardiol; 1986 Feb; 57(7):50D-53D. PubMed ID: 3006467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A symposium: Calcium antagonists in hypertension--focus on verapamil. November 15-17, 1985, Mexico City, Mexico. November 27, 1984, Bangkok, Thailand.
    Am J Cardiol; 1986 Feb; 57(7):1D-107D. PubMed ID: 3953426
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium channel blockers blunt postural cutaneous vasoconstriction in hypertensive patients.
    Iabichella ML; Dell'Omo G; Melillo E; Pedrinelli R
    Hypertension; 1997 Mar; 29(3):751-6. PubMed ID: 9052891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists as first-choice therapy for low-renin essential hypertension.
    Bühler FR
    Kidney Int; 1989 Aug; 36(2):295-305. PubMed ID: 2674520
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose initiation of calcium antagonists in the treatment of hypertension.
    Müller FB; Erne P; Hotz M; Bolli P; Follath F; Bühler FR
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):118S-124S. PubMed ID: 3794763
    [No Abstract]   [Full Text] [Related]  

  • 7. Calcium antagonists as a new treatment modality in hypertension.
    Laragh JH
    Angiology; 1988 Jan; 39(1 Pt 2):100-5. PubMed ID: 3277491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium antagonists into the nineties: appraisal and future trends. Verapamil satellite symposium to the 25th anniversary International Symposium on Calcium Antagonists. Basel, Switzerland, February 12, 1988.
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S1-82. PubMed ID: 2475675
    [No Abstract]   [Full Text] [Related]  

  • 9. Calcium antagonists and beta blockers in the control of mild to moderate systemic hypertension, with particular reference to verapamil and propranolol.
    Singh BN; Rebanal P; Piontek M; Nademanee K
    Am J Cardiol; 1986 Feb; 57(7):99D-105D. PubMed ID: 2869676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists in the treatment of hypertension: a critical overview.
    Weidmann P; Gerber A; Laederach K
    Adv Nephrol Necker Hosp; 1985; 14():197-232. PubMed ID: 3919532
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists in the treatment of moderate arterial hypertension].
    Mazur NA; Titov VN; Nazerov EA; Iudaev AE
    Kardiologiia; 1989 Nov; 29(11):125-8. PubMed ID: 2693795
    [No Abstract]   [Full Text] [Related]  

  • 12. The place of the calcium antagonist verapamil in antihypertensive therapy.
    Bühler FR; Hulthén UL; Kiowski W; Müller FB; Bolli P
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S350-7. PubMed ID: 6184567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists in the management of hypertension].
    Kaburagi T; Yokoyama S
    Nihon Rinsho; 1984 Feb; 42(2):409-15. PubMed ID: 6716696
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the renin-angiotensin system and the effectiveness of the treatment of hypertension with calcium antagonists, beta-adrenoblockers and diuretics].
    Svishchenko EP
    Kardiologiia; 1992 Sep; 32(9-10):41-4. PubMed ID: 1363127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemodynamics of calcium-channel antagonists in hypertension: vascular and myocardial responses.
    Cody RJ
    Circulation; 1987 Jan; 75(1 Pt 2):I175-9. PubMed ID: 3791618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium antagonists in the treatment of nephrogenic hypertension].
    Tareeva IE; Kutyrina IM; Galstian GM; Rogov VA
    Klin Med (Mosk); 1990 Aug; 68(8):52-6. PubMed ID: 2084371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal effects of calcium antagonists].
    Leonetti G
    Cardiologia; 1984; 29(9-10):439-41. PubMed ID: 6543509
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term management of hypertension with verapamil.
    Lewis GR
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():107-12. PubMed ID: 6811175
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical application of verapamil in patients with supraventricular cardiac rhythm disturbances and arterial hypertension].
    Volkov VE; Babaev FZ; Pshenitsin AI; Zhezheva FM; Mazur NA
    Kardiologiia; 2008; 48(7):30-4. PubMed ID: 18789023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.